Guitar Heroes Raising Money to Fight Lymphoma

A youth program called h4O [‘Help to Others’] out of the city of Lakewood, Ohio’s Department Of Human Services has found a clever and resourceful way of raising money for The Leukemia & Lymphoma Society.



On Saturday, March 21st in Lakewood High School’s East Cafeteria between 11am and 2pm, h4O is hosting a Guitar Hero Tournament.



It's the group's second annual tournament. Last year they raised a fantastic $700 and this year they’re gunning for $1,000. If you live in the Lakewood area, are in grades 6-12, and want to test out your GH chops against others for a good cause, download an entry form from their website and register by March 13th.



Cash prizes go to the winners, and admission for spectators is just a dollar. Plus, they'll have a Rock Band station set up that will only cost a dollar to play.



More information is available here.



If you don't live in the area but you're an avid Guitar Hero player, or Rock Band, or any other kind of gamer, use this example to put together your own event to raise money for a good cause. It might be to fund research to find a cure for cancer, or maybe to afford to buy laptop computers for kids with lymphoma who are in treatment in the hospital and missing school work. Every bit helps, and the results are always worth the effort.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap